Metformin in diabetic pregnancy

Journal of the Royal College of Physicians of Edinburgh

Volumn 39, Issue 1, 2009, Pages 10-14

  Swaminathan, K ^a   Howlett, H C S ^b   Campbell, I W ^a  

^a VICTORIA HOSPITAL   (United Kingdom)

^b University of St Andrews ^*

Author keywords

Diabetes; Metformin; Pregnancy

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; INSULIN; METFORMIN;

CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; REVIEW; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; TREATMENT RESPONSE; WEIGHT REDUCTION;

EID: 70349640900     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Confidential Enquiry into Maternal and Child Health. Pregnancy in women with with Type 1 and Type 2 diabetes in 2002-3. London: CEMACH; 2005.
2. Bell PM, Hadden DR. Metformin. Endocrinol Metab Clin North Am 1997; 26:523-37.
3. Witters LA. The blooming of the French lilac. J Clin Invest 2001; 108:1105-7.
4. Bailey CJ, Wilcock C, Day C. Effect of metformin on glucose metabolism in the splanchnic bed. Br J Pharmacol 1992; 105:1009-13.
5. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996; 334:574-9.
6. Rossetti L, DeFronzo RA, Ciherzi R et al. Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. Metabolism 1990; 39:425-35.
7. Stumvoll M, Nurjhan N, Perriello et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333:550-4.
8. Bailey CJ, Mynett KJ, Page T. Importance of the intestine as a site of metformin-stimulated glucose utilization. Br J Pharmacol 1994; 112:671-5.
9. Zhou G, Myers R, Li Y et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108:1167-74.
10. Feig DS, Briggs GG, Koren G. Oral antidiabetic agents in pregnancy and lactation: a paradigm shift? Ann Pharmacother 2007; 41:1174-80.
11. Charles B, Norris R, Xiao X et al. Population pharmacokinetics of metformin in late pregnancy. Ther Drug Monit 2006; 28:67-72.
12. Hong YC, O'Boyle CP, Chen IC et al. Metformin-associated lactic acidosis in a pregnant patient. Gynecol Obstet Invest 2008; 66:138-41.
13. Coetzee EJ, Jackson WP. Diabetes newly diagnosed during pregnancy: a 4-year study at Groote Schuur Hospital. S Afr Med J 1979; 56:467-75.
14. Coetzee EJ, Jackson WP. Pregnancy in established non-insulindependent diabetics. A five-and-a-half year study at Groote Schuur Hospital. S Afr Med J 1980; 58:795-802.
15. Coetzee EJ, Jackson WP. The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res Clin Pract 1985;1:281-7.
16. Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med 2000; 17:507-11.
17. Glueck CJ, Phillips H, Cameron D et al. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 2001; 75:46-52.
18. Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 2006; 86:658-63.
19. McCarthy EA, Walker SP, McLachlan K et al. Metformin in obstetric and gynecologic practice: a review. Obstet Gynecol Surv 2004; 59:118-27.
20. Glueck CJ, Wang P, Kobayashi S et al. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002; 77:520-5.
21. Huang DY, Usher RH, Kramer MS et al. Determinants of unexplained antepartum fetal deaths. Obstet Gynecol 2000; 95:215-21.
22. Sibai BM, Gordon T, Thom E et al. Risk factors for pre-eclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995; 172:642-8.
23. Cnattingius S, Bergström R, Lipworth L et al. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998; 338:147-52.
24. Hughes RC, Rowan JA. Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome? Diabet Med 2006; 23:318-22.
25. Rowan JA, Hague WM, Gao W et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008; 358:2003-15.
26. Glueck CJ, Goldenberg N, Pranikoff J et al. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004; 19:1323-30.
27. Balani JHS, Rodin A, Shetata H. Pregnancy outcomes in metformin treated women with gestational diabetes. Diabetologia 2008; 51 (Suppl 1):S467.
28. Gardiner SJ, Kirkpatrick CM, Begg EJ et al. Transfer of metformin into human milk. Clin Pharmacol Ther 2003; 73:71-7.
29. Hale TW, Kristensen JH, Hackett LP et al. Transfer of metformin into human milk. Diabetologia 2002; 45:1509-14.
30. Briggs GG, Ambrose PJ, Nageotte MP et al. Excretion of metformin into breast milk and the effect on nursing infants. Obstet Gynecol 2005; 105:1437-41.
31. Management of diabetes from preconception to the postnatal period: summary of NICE guidance. BMJ 2008; 336:714-7.
32. Glueck CJ, Salehi M, Sieve L et al. Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome. J Pediatr 2006; 148:628-32.
33. Moore LE, Briery CM, Clokey D et al. Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. J Reprod Med 2007; 52:1011-5.
34. Langer O, Conway DL, Berkus MD et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000; 343:1134-8.
35. Jacobson GF, Ramos GA, Ching JY et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 2005;193:118-24.
36. Mathiesen ER, Damm P. Commentary from Copenhagen on the NICE guideline on management of diabetes and its complications from preconception to the post-natal period. Diabetic Med 2008; 25:1028-9.
37. Jovanovic L. Point: Oral hypoglycaemic agents should not be used to treat diabetic pregnant women. Diabetes Care 2007; 30:2976-9.
38. Coetzee EJ. Counterpoint: oral hypoglycaemic agents should be used to treat diabetic pregnant women. Diabetes Care 2007; 30: 2980-2.
39. Ekpebegh CO, Coetzee EJ, van der Merwe L et al. A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents. Diabetic Med 2007; 24:253-8.
40. Jones KL, Arslanian S, Peterokova VA et al. Effect of metformin in paediatric patients with Type 2 diabetes. Diabetes Care 2002; 25: 89-94.
41. Srinivasan S, Ambler GR, Baur LA. Randomised controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin. J Clin Endocrinol Metab 2006; 91:2074-80.
42. Klein DJ, Cottingham EM, Sorter M et al. A randomised double blind placebo controlled trial of metformin treatment of weight gain associated with initiation of atypical anti-psychotic therapy in children and adolescents. Am J Psychiatry 2006; 163:2072-9.
43. Hawthorne G. Metformin use and diabetic pregnancy - has its time come? Diabetic Med 2006; 23:223-7.
44. Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care 2008; 31:1668-9.
45. Ratner RE, Christophi CA, Metzger BE et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008; 93:4774-9.
46. UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight type 2 diabetes (UKPDS 34). Lancet 1998: 352:854-65.
47. Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in Type 2 diabetes. N Eng J Med 2008; 359: 1577-89.